This company seems to have been delisted
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
PerkinElmer
PKI
£89.23
Share price
-0.91%
Change (1 day)
-28.97%
Change (1 year)
Categories
PerkinElmer, Inc. is an American chemical and medical technology company with operations in environmental health and human health.
PerkinElmer (PKI) - Net assets
Net assets on the balance sheet as of March 2023 : £6.22 Billion
According to PerkinElmer
's latest financial reports the company has £6.22 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
PerkinElmer - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $£6.11 B | 15.68% |
| 2021-12-31 | $£5.28 B | 92.75% |
| 2020-12-31 | $£2.74 B | 27.71% |
| 2019-12-31 | $£2.14 B | 5.37% |
| 2018-12-31 | $£2.03 B | 9.95% |
| 2017-12-31 | $£1.85 B | 6.12% |
| 2016-12-31 | $£1.74 B | 22.55% |
| 2015-12-31 | $£1.42 B | 8.58% |
| 2014-12-31 | $£1.31 B | 8.61% |
| 2013-12-31 | $£1.20 B | 0.63% |
| 2012-12-31 | $£1.20 B | 1.31% |
| 2011-12-31 | $£1.18 B | -5.04% |
| 2010-12-31 | $£1.24 B | 23.93% |
| 2009-12-31 | $£1.00 B | -5.91% |
| 2008-12-31 | $£1.06 B | 34.92% |
| 2007-12-31 | $£0.79 B | -1.56% |
| 2006-12-31 | $£0.80 B | -15.84% |
| 2005-12-31 | $£0.95 B | 25.85% |
| 2004-12-31 | $£0.76 B | 0.85% |
| 2003-12-31 | $£0.75 B | -3.44% |
| 2002-12-31 | $£0.78 B | -16.95% |
| 2001-12-31 | $£0.94 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | £38.46 B | 518.29% | 🇺🇸 USA |
 | £1.41 B | -77.24% | 🇺🇸 USA |
 | £4.56 B | -26.59% | 🇺🇸 USA |
 | £1.40 B | -77.41% | 🇺🇸 USA |
 | £5.08 B | -18.23% | 🇺🇸 USA |
 | £19.51 B | 213.72% | 🇺🇸 USA |
 | £1.83 B | -70.46% | 🇺🇸 USA |